Apollo Endosurgery Inc Book/Share
What is the Book/Share of Apollo Endosurgery Inc?
The Book/Share of Apollo Endosurgery Inc is 0.83
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Apollo Endosurgery Inc
What does Apollo Endosurgery Inc do?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Companies with book/share similar to Apollo Endosurgery Inc
- Fast Finance24 AG has Book/Share of 0.83
- ITM Power Plc has Book/Share of 0.83
- China Shandong Hi-Speed has Book/Share of 0.83
- WildBrain has Book/Share of 0.83
- Chongqing Iron & Steel has Book/Share of 0.83
- A8 New Media has Book/Share of 0.83
- Apollo Endosurgery Inc has Book/Share of 0.83
- ECN Capital has Book/Share of 0.83
- JD Sports Fashion plc has Book/Share of 0.83
- COSCO SHIPPING Development Co has Book/Share of 0.83
- China Eco-Farming has Book/Share of 0.83
- Gordon Pointe Acquisition has Book/Share of 0.83
- Concord New has Book/Share of 0.83